NRXP
NRX Pharmaceuticals Inc
NASDAQ: NRXP · HEALTHCARE · BIOTECHNOLOGY
$2.98
+2.41% today
Updated 2026-04-30
Market cap
$100.19M
P/E ratio
—
P/S ratio
81.79x
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$2 – $4
Volume
0.9M
NRX Pharmaceuticals Inc (NRXP) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |